Should You Add GT Biopharma Inc (GTBP) Stock to Your Portfolio Monday?

Monday, November 13, 2023 12:50 PM | InvestorsObserver Analysts

Mentioned in this article

Should You Add GT Biopharma Inc (GTBP) Stock to Your Portfolio Monday?

GT Biopharma Inc (GTBP) is near the middle in its sector according to InvestorsObserver. GTBP gets an overall rating of 1. That means it scores higher than 1% of stocks. GT Biopharma Inc gets a 37 rank in the Healthcare sector. Healthcare is number 5 out of 11 sectors.

GTBP has an Overall Score of 1. Find out what this means to you and get the rest of the rankings on GTBP!

See Full GTBP Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With GT Biopharma Inc Stock Today?

GT Biopharma Inc (GTBP) stock is down -2.17% while the S&P 500 is higher by 0.02% as of 12:07 PM on Monday, Nov 13. GTBP has fallen -$0.01 from the previous closing price of $0.24 on volume of 55,665 shares. Over the past year the S&P 500 has gained 11.60% while GTBP has fallen -89.05%. GTBP lost -$0.29 per share the over the last 12 months. Click Here to get the full Stock Report for GT Biopharma Inc stock.